Abate Kristin sold KPTI
September 15, 2025 · Form 4 insider transaction
Abate Kristin sold 23 shares of Karyopharm Therapeutics Inc. at $6.43 per share, a transaction worth $147.89. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
23
Price
$6.43
Total value
$147.89
InsiderAbate Kristin
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 15, 2025
Filing dateSeptember 16, 2025
Shares owned after10,408
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 27, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of PSUs. The sale does not represent a discretionary trade by the reporting person.